Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients that can be treated with endovascular treatment, but are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.
With StrokePointer from TrianecT, we combine brain activity measurement and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to their best treatment. This saves time and time = brain.
Dr. Wouter Potters
Dr. Jonathan Coutinho
Dr. Henk Marquering
Dr. Frank Zanow
Simon van Bezooijen
Amsterdam Science & Innovation Award
First clinical trial results
Do you want to join our mission to improve acute stroke care?
Then connect with us at email@example.com
Are you a talented and self-driven student looking for an internship? Do you want to take on a challenge in our young and dynamic start-up? We welcome internship applications of excellent candidates (for example on marketing, sales, medical software development or UX design). Make sure to attach your curriculum vitae and your motivation letter when applying.Apply at firstname.lastname@example.org